Risk Factors for Treatment-Related Death Associated with Chemotherapy and Thoracic Radiotherapy for Lung Cancer
- 1 January 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 7 (1), 177-182
- https://doi.org/10.1097/jto.0b013e31823c4c07
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in JapanAnnals Of Oncology, 2006
- Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patientsRadiotherapy and Oncology, 2006
- Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non–Small-Cell Lung Cancer Patients Treated With GefitinibJournal of Clinical Oncology, 2006
- Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patientsAnnals Of Oncology, 2006
- Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderlyCancer, 2005
- The Outcome of Combined-Modality Therapy for Stage III Non–Small-Cell Lung Cancer in the ElderlyJournal of Clinical Oncology, 2003
- Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Similar outcome of elderly patients in Intergroup Trial 0096Cancer, 2000
- Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified?Lung Cancer, 1994
- Predicting septic complications of chemotherapy: An analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsisEuropean Journal Of Cancer, 1993